Neurocrine Biosciences, Inc.
3 drugs in NADAC|0 Generic,3 Brand
Neurocrine Biosciences, Inc. lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $284.74 per unit, with a week-over-week move of +3.5% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
3
0G / 3B
Avg Price / Unit
$284.7389
$270.59 – $291.82
Avg 7d Change
+3.50%
Across 3 drugs with changes
7d Activity
of 3 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
Valbenazine market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Vesicular Monoamine Transporter 2 Inhibitor therapeutic class
Review the broader class where Neurocrine Biosciences, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Neurocrine Biosciences, Inc. make?
Neurocrine Biosciences, Inc. lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.
What is the average price of Neurocrine Biosciences, Inc. drugs?
The average NADAC across Neurocrine Biosciences, Inc.'s portfolio is $284.7389 per unit, ranging from $270.5863 to $291.8152.
What types of drugs does Neurocrine Biosciences, Inc. make?
Neurocrine Biosciences, Inc. makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Vesicular Monoamine Transporter 2 Inhibitor (3).
Has Neurocrine Biosciences, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Neurocrine Biosciences, Inc. in the openFDA feed.
How has Neurocrine Biosciences, Inc.'s pricing changed recently?
Over the past 7 days, 3 Neurocrine Biosciences, Inc. products rose and 0 fell, with a portfolio-wide average change of +3.5%.
| Watch | Drug ↕ | Price | 7d Change ↕ |
|---|---|---|---|
INGREZZA 60 MG CAPSULE Valbenazine | $291.8152 per EA | +3.00% | |
INGREZZA 80 MG CAPSULE Valbenazine | $291.8152 per EA | +3.00% | |
INGREZZA 40 MG CAPSULE Valbenazine | $270.5863 per EA | +4.50% |